Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 2067-2071, December 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maenza, R. M.
Right arrow Articles by Sunderman, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maenza, R. M.
Right arrow Articles by Sunderman, F. W., Jr.

Rapid Induction of Sarcomas in Rats by Combination of Nickel Sulfide and 3,4-Benzpyrene1

Ronald M. Maenza, Arun M. Pradhan and F. William Sunderman, Jr.2

Departments of Pathology [R. M. M.] and Laboratory Medicine [A. M. P., F. W. S.], University of Connecticut Health Center, Farmington, Connecticut 06032

The interval between administration of carcinogen and development of sarcomas was significantly shorter in male Fischer rats that received bilateral injections into thigh muscles of a combination of 10 mg of Ni3S2 and 5 mg of 3,4-benzpyrene (Group C) than in rats that received only 10 mg of Ni3S2 (Group A) or only 5 mg of 3,4-benzpyrene (Group B). No sarcomas developed in control rats (Group D), which received only the injection vehicle (pencillin suspension). The period between injection of carcinogens and initial palpation of tumors at the injection sites averaged 18 ± 3 weeks in Group C versus 26 ± 5 weeks in Group A and 31 ± 10 weeks in Group B (p < 0.001). The period between injection of carcinogens and death from sarcoma averaged 24 ± 5 weeks in Group C versus 33 ± 5 weeks in Group A and 41 ± 11 weeks in Group B (p < 0.001). The proportion of primary sarcomas which were classified as rhabdomyosarcomas was 91% in Group C versus 81% in Group A and 13% in group B. This study furnishes (a) additional support for speculations concerning carcinogenic interaction between nickel compounds and polycyclic aromatic hydrocarbons and (b) a rapid and convenient experimental technique for inducing rhabdomyosarcomas in rats. This technique is well adapted for use as a laboratory exercise in neoplasia for pathology students.

1 Sponsored by United States Atomic Energy Commission Grant AT(30-1)4051; by USPHS Grant CA-11250 from the National Cancer Institute; and by United States Environmental Protection Agency Contract EHS-C-71-NEG-109.

2 To whom requests for reprints should be addressed at P. O. Drawer B, Newington, Conn. 06111.

Received 7/ 2/71. Accepted 7/29/71.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. Davidson, K. Salnikow, and M. Costa
Hypoxia Inducible Factor-1{alpha}-Independent Suppression of Aryl Hydrocarbon Receptor-Regulated Genes by Nickel
Mol. Pharmacol., December 1, 2003; 64(6): 1485 - 1493.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.